Synopsis: GlaxoSmithKline has voluntarily paused activities in its Phase III GRACE trial on an experimental…
Tag:
Consumer
-
-
Gsk
GlaxoSmithKline’s Novel Anemia (Daprodustat) has Notched up A First-In-Class Success While AstraZeneca-FibroGen’s Akebia Failed.
by adminSYNOPSIS: GlaxoSmithKline Plc released positive trial results for a potential blockbuster anemia pill the company…